MM

Mohd Mubeen

Active Director Director DIN 10095464
DIN 10095464 First appointment Mar 2023 Primary industry Wood
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 2 active board seats
Total affiliations 2 Since Mar 2023
Shareholding value β€’β€’β€’β€’ Premium profile

About Mohd Mubeen

Data last updated:

Mohd Mubeen is a Director at Amuk Feed Corporation Private Limited (since 2024) and Director at Amuk Pharma Private Limited (since 2023). The companies operate in Wood.

DIN 10095464
Primary Designation Director
Industry Wood
First Appointment 30 Mar 2023
Oldest Company Age 3 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director05 Mar 20242024Active
Amuk Pharma Private Limited U20299UT2023PTC015402
Director30 Mar 20232023Active

Board colleagues of Mohd Mubeen

Directorship timeline

Open interactive timeline →
Amuk Pharma Private Limited
Amuk Feed Corporation Private Limited
Premium access

Shareholding and investment profile for Mohd Mubeen

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Mohd Mubeen

Mohd Mubeen currently holds 2 directorships: Amuk Feed Corporation Private Limited (Director, since 05 Mar 2024); Amuk Pharma Private Limited (Director, since 30 Mar 2023).

Mohd Mubeen was first appointed on 30 Mar 2023 as Director at Amuk Pharma Private Limited. The most recent appointment on record is 05 Mar 2024 at Amuk Feed Corporation Private Limited.

The current boards of Mohd Mubeen's companies include Atiulla (Amuk Feed Corporation Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available